These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 314248)

  • 1. Levamisole in systemic lupus erythematosus.
    Ogawa K; Sano T; Hisano G; Tsubura E
    Ann Allergy; 1979 Sep; 43(3):187-9. PubMed ID: 314248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levamisole maintains cyclophsophamide-induced remission in murine lupus erythematosus.
    Zulman J; Michalski J; McCombs C; Greenspan J; Talal N
    Clin Exp Immunol; 1978 Feb; 31(2):321-7. PubMed ID: 306328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experience with levamisole treatment of patients with systemic lupus erythematosus (author's transl)].
    Scherak O; Smolen J; Kolarz G; Kojer M; Menzel J
    Wien Klin Wochenschr; 1979 Nov; 91(22):758-62. PubMed ID: 160142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of systemic lupus erythematosus with the T-cell immunopotentiator levamisole: a follow-up report of 16 patients under treatment for a minimum period of four months.
    Gordon BL; Yanagihara R
    Ann Allergy; 1977 Oct; 39(4):227-36. PubMed ID: 71868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of levamisole on immunological parameters in patients with systemic lupus erythematosus.
    Scherak O; Smolen JS; Menzel EJ; Kojer M; Kolarz G
    Scand J Rheumatol; 1980; 9(2):106-12. PubMed ID: 6968971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Levamisole and its effect on the E-rosette restoration test in healthy subjects and in systemic lupus erythematosus (author's transl)].
    Rovenský J; Pekárek J; Holt PJ; Mistina T; Zitnan D
    Cas Lek Cesk; 1981 Jun; 120(25):761-3. PubMed ID: 7260993
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic trials with levamisole and other agents in NZB/W mice.
    Russell AS
    J Rheumatol; 1976 Dec; 3(4):380-3. PubMed ID: 1088166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levamisole in the treatment of systemic lupus erythematosus--preliminary results.
    Feng PH; Oon CJ; Yo SL; Lau YK
    Singapore Med J; 1978 Sep; 19(3):120-4. PubMed ID: 751195
    [No Abstract]   [Full Text] [Related]  

  • 9. Study of lymphocyte subpopulations in patients with systemic lupus erythematosus. In vitro effect of levamisole on T-lymphocyte population.
    Pozsonyi T; Jakab L; Fehér J
    Allergol Immunopathol (Madr); 1980; 8(5):553-8. PubMed ID: 6970515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lupus nephritis: clinical course in relation to treatment.
    Nanra RS; Kincaid-Smith P
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1193-210. PubMed ID: 4803309
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of levamisole in lupus nephritis].
    Horiuchi A
    Nihon Jinzo Gakkai Shi; 1979 Apr; 21(4):280-3. PubMed ID: 480701
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic lupus erythematosus: observations on long-term survivors of "suppressive" therapy of lupus nephritis with prednisolone.
    Mackay IR
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1211-7. PubMed ID: 4139686
    [No Abstract]   [Full Text] [Related]  

  • 13. A case of systemic lupus erythematosus presenting with protein-losing enteropathy.
    Türkçapar N; Ozyüncü N; Cinar K; Ensari A; Küçük O; Idilman R; Duman N; Ozden A
    Turk J Gastroenterol; 2006 Sep; 17(3):226-30. PubMed ID: 16941261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Crithidia luciliae kinetoplast immunofluorescence test in systemic lupus erythematosus.
    Slater NG; Cameron JS; Lessof MH
    Clin Exp Immunol; 1976 Sep; 25(3):480-6. PubMed ID: 786521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis.
    Adu D; Williams DG; Taube D; Vilches AR; Turner DR; Cameron JS; Ogg CS
    Q J Med; 1983; 52(208):471-87. PubMed ID: 6606818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of levamisole (Decaris) on various immunologic parameters in patients with systemic lupus erythematosus].
    Gandzha IM; Sakharchuk VM; Lysenko GI
    Ter Arkh; 1981; 53(7):121-4. PubMed ID: 6457406
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serum anti-dsDNA antibodies in lupus nephritis].
    Fiorentini GP; Cagnoli L
    Boll Soc Ital Biol Sper; 1981 Sep; 57(18):1890-5. PubMed ID: 7032540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro effect of thymic humoral factor and levamisole on peripheral blood lymphocytes in systemic lupus erythematosus patients.
    Michalevicz R; Many A; Ramot B; Trainin N
    Clin Exp Immunol; 1978 Jan; 31(1):111-5. PubMed ID: 639342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of lupus nephritis in childhood].
    Taubert M; Döring E
    Padiatr Grenzgeb; 1983; 22(2-3):191-4. PubMed ID: 6888932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.